Search research articles
Contact Us
Filters
Showing results (401-410 of 527) with videos related to
Page
of 53
Sort By:
Acta Psychiatrica Scandinavica
|
January 21, 2006
An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia
D C Henderson, L Kunkel, D D Nguyen, et al.
Biological Psychiatry
|
June 5, 2007
Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia
Joshua L Roffman, Anthony P Weiss, Shaun Purcell, et al.
BMC Medical Research Methodology
|
September 25, 2016
Description and initial evaluation of incorporating electronic follow-up of study participants in a longstanding multisite cohort study
Kiarri N Kershaw, Kiang Liu, David C Goff, et al.
The Journal of Clinical Psychiatry
|
September 29, 2005
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia
A Eden Evins, Thilo Deckersbach, Corinne Cather, et al.
JAMA
|
April 1, 2014
Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations
Paul Muntner, Lisandro D Colantonio, Mary Cushman, et al.
American Journal of Human Genetics
|
June 1, 1986
Characterization of a spontaneous mutation to a beta-thalassemia allele
H H Kazazian, S H Orkin, C D Boehm, et al.
Molecular and Cellular Biology
|
September 1, 1993
Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner
P A Ney, N C Andrews, S M Jane, et al.
Diabetes Care
|
September 12, 2015
Duration and Degree of Weight Gain and Incident Diabetes in Younger Versus Middle-Aged Black and White Adults: ARIC, CARDIA, and the Framingham Heart Study
Gina S Wei, Sean A Coady, Jared P Reis, et al.
Schizophrenia Research
|
September 3, 2005
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
Joseph P McEvoy, Jonathan M Meyer, Donald C Goff, et al.
JAMA Psychiatry
|
March 8, 2013
Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia
Joshua L Roffman, J Steven Lamberti, Eric Achtyes, et al.
Page
of 53
Search research articles
Search
Showing results (401-410 of 527) with videos related to
Sort By:
Page
of 53
Acta Psychiatrica Scandinavica
|
January 21, 2006
An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia
D C Henderson, L Kunkel, D D Nguyen, et al.
Biological Psychiatry
|
June 5, 2007
Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia
Joshua L Roffman, Anthony P Weiss, Shaun Purcell, et al.
BMC Medical Research Methodology
|
September 25, 2016
Description and initial evaluation of incorporating electronic follow-up of study participants in a longstanding multisite cohort study
Kiarri N Kershaw, Kiang Liu, David C Goff, et al.
The Journal of Clinical Psychiatry
|
September 29, 2005
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia
A Eden Evins, Thilo Deckersbach, Corinne Cather, et al.
JAMA
|
April 1, 2014
Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations
Paul Muntner, Lisandro D Colantonio, Mary Cushman, et al.
American Journal of Human Genetics
|
June 1, 1986
Characterization of a spontaneous mutation to a beta-thalassemia allele
H H Kazazian, S H Orkin, C D Boehm, et al.
Molecular and Cellular Biology
|
September 1, 1993
Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner
P A Ney, N C Andrews, S M Jane, et al.
Diabetes Care
|
September 12, 2015
Duration and Degree of Weight Gain and Incident Diabetes in Younger Versus Middle-Aged Black and White Adults: ARIC, CARDIA, and the Framingham Heart Study
Gina S Wei, Sean A Coady, Jared P Reis, et al.
Schizophrenia Research
|
September 3, 2005
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
Joseph P McEvoy, Jonathan M Meyer, Donald C Goff, et al.
JAMA Psychiatry
|
March 8, 2013
Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia
Joshua L Roffman, J Steven Lamberti, Eric Achtyes, et al.
Page
of 53